MedTech Dive February 24, 2025
The brain-computer interface technology personalizes therapy based on an individual’s brain activity.
Dive Brief:
- Medtronic received Food and Drug Administration approval for the BrainSense Adaptive deep brain stimulation (DBS) device for people with Parkinson’s disease, a movement disorder of the nervous system.
- The adaptive BrainSense device self-adjusts therapy to a person’s brain activity, minimizing the need for manual adjustments. The approval was the first of an adaptive DBS device for Parkinson’s, Medtronic said in a Monday announcement.
- Medtronic claims the launch of the system will be the largest ever commercial rollout of a brain-computer interface technology.
Dive Insight:
Medtronic’s DBS system uses an implanted neurostimulator to transmit electrical signals to areas of the brain affected by neurological disorders,...
Today's Sponsors
Today's Sponsor